{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:53:36Z","timestamp":1790805216312,"version":"4.1.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,9]],"date-time":"2021-11-09T00:00:00Z","timestamp":1636416000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012638","name":"Valerion Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013220","name":"Ultragenyx Pharmaceutical Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013220","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TL1 TR002555"],"award-info":[{"award-number":["TL1 TR002555"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Genetics and Metabolism Reports"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.ymgmr.2021.100821","type":"journal-article","created":{"date-parts":[[2021,11,11]],"date-time":"2021-11-11T05:44:02Z","timestamp":1636609442000},"page":"100821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III"],"prefix":"10.1016","volume":"29","author":[{"given":"Ghada","family":"Hijazi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paschall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah P.","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura E.","family":"Case","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Boggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathya","family":"Amarasekara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie L.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surekha","family":"Pendyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areeg","family":"El-Gharbawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen L.","family":"Deak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya S.","family":"Kishnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0005","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0888-7543(92)90003-B","article-title":"Assignment of the human glycogen debrancher gene to chromosome 1p21","volume":"13","author":"Yang-Feng","year":"1992","journal-title":"Genomics"},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100821_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/geno.1996.0611","article-title":"Human glycogen debranching enzyme gene (AGL): complete structural organization and characterization of the 5\u2019 flanking region","volume":"38","author":"Bao","year":"1996","journal-title":"Genomics"},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0015","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1432-1033.1967.tb00134.x","article-title":"The subgroups of type 3 glycogenosis","volume":"2","author":"Van Hoof","year":"1967","journal-title":"Eur. J. Biochem."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100821_bb0020","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0022-3476(05)81652-X","article-title":"Immunoblot analyses of glycogen debranching enzyme in different subtypes of glycogen storage disease type III","volume":"116","author":"Ding","year":"1990","journal-title":"J. Pediatr."},{"issue":"11","key":"10.1016\/j.ymgmr.2021.100821_bb0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/jhg.2009.100","article-title":"Molecular features of 23 patients with glycogen storage disease type III in Turkey: a novel mutation p. R1147G associated with isolated glucosidase deficiency, along with 9 AGL mutations","volume":"54","author":"Aoyama","year":"2009","journal-title":"J. Hum. Genet."},{"issue":"7","key":"10.1016\/j.ymgmr.2021.100821_bb0030","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/GIM.0b013e3181e655b6","article-title":"Glycogen storage disease type III diagnosis and management guidelines","volume":"12","author":"Kishnani","year":"2010","journal-title":"Genet Med."},{"issue":"12","key":"10.1016\/j.ymgmr.2021.100821_bb0035","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1038\/s41436-019-0561-7","article-title":"Liver fibrosis during clinical ascertainment of glycogen storage disease type III: a need for improved and systematic monitoring","volume":"21","author":"Halaby","year":"2019","journal-title":"Genet Med."},{"issue":"5","key":"10.1016\/j.ymgmr.2021.100821_bb0040","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s10545-016-9932-2","article-title":"Glycogen storage disease type III: diagnosis, genotype, management, clinical course and outcome","volume":"39","author":"Sentner","year":"2016","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0045","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2006.09.022","article-title":"Glycogen storage disease type III-hepatocellular carcinoma a long-term complication?","volume":"46","author":"Demo","year":"2007","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100821_bb0050","first-page":"37","article-title":"Diurnal variability of glucose tetrasaccharide (Glc4) excretion in patients with glycogen storage disease type III","volume":"58","author":"Young","year":"2020","journal-title":"JIMD Rep."},{"issue":"11","key":"10.1016\/j.ymgmr.2021.100821_bb0055","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s00431-015-2546-0","article-title":"Skeletal and cardiac muscle involvement in children with glycogen storage disease type III","volume":"174","author":"Mogahed","year":"2015","journal-title":"Eur. J. Pediatr."},{"issue":"7","key":"10.1016\/j.ymgmr.2021.100821_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/GIM.0b013e3181e0e979","article-title":"Echocardiographic manifestations of glycogen storage disease III: increase in wall thickness and left ventricular mass over time","volume":"12","author":"Vertilus","year":"2010","journal-title":"Genet Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1007\/BF01744800","article-title":"Cardiomyopathy of glycogen storage disease type III","volume":"8","author":"Carvalho","year":"1993","journal-title":"Heart Vessel."},{"issue":"8","key":"10.1016\/j.ymgmr.2021.100821_bb0070","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/BF00443106","article-title":"Cardiac involvement in glycogen storage disease type III","volume":"148","author":"Moses","year":"1989","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.ymgmr.2021.100821_bb0075","first-page":"198","article-title":"Hypertrophic cardiomyopathy in glycogen storage disease type III: clinical features and long-term outcome","volume":"10","author":"Chong-Nguyen","year":"2018","journal-title":"Arch. Cardiovasc. Dis. Suppl."},{"issue":"7","key":"10.1016\/j.ymgmr.2021.100821_bb0080","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/0002-9149(84)90551-4","article-title":"Cardiac involvement in glycogen storage disease III: morphologic and biochemical characterization with endomyocardial biopsy","volume":"53","author":"Olson","year":"1984","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ymgmr.2021.100821_bb0085","first-page":"65","article-title":"Cardiac pathology in glycogen storage disease type III","volume":"6","author":"Austin","year":"2012","journal-title":"JIMD Rep."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0090","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/oxfordjournals.eurheartj.a015283","article-title":"Specific heart muscle disease associated with glycogen storage disease type III: clinical similarity to the dilated phase of hypertrophic cardiomyopathy","volume":"18","author":"Akazawa","year":"1997","journal-title":"Eur. Heart J."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0095","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-8703(95)90097-7","article-title":"Glycogen storage disease type III associated with ventricular tachycardia","volume":"130","author":"Tada","year":"1995","journal-title":"Am. Heart J."},{"issue":"8","key":"10.1016\/j.ymgmr.2021.100821_bb0100","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1136\/hrt.34.8.862","article-title":"Gross cardiac involvement in glycogen storage disease type 3","volume":"34","author":"Miller","year":"1972","journal-title":"Br. Heart J."},{"issue":"11","key":"10.1016\/j.ymgmr.2021.100821_bb0105","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1046\/j.1464-5491.2000.00378.x","article-title":"Diabetes mellitus secondary to glycogen storage disease type III","volume":"17","author":"Oki","year":"2000","journal-title":"Diabet. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100821_bb0110","doi-asserted-by":"crossref","first-page":"6891","DOI":"10.4076\/1757-1626-2-6891","article-title":"Glycogen storage disease type III presenting with secondary diabetes and managed with insulin: a case report","volume":"17","author":"Ismail","year":"2009","journal-title":"Cases J."},{"key":"10.1016\/j.ymgmr.2021.100821_bb0115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.bone.2016.02.012","article-title":"Reduced bone mineral density in glycogen storage disease type III: evidence for a possible connection between metabolic imbalance and bone homeostasis","volume":"86","author":"Melis","year":"2016","journal-title":"Bone"},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100821_bb0120","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2265.1995.tb02686.x","article-title":"The prevalence of polycystic ovaries in the hepatic glycogen storage diseases: its association with hyperinsulinism","volume":"42","author":"Lee","year":"1995","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100821_bb0125","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10545-011-9384-7","article-title":"Pregnancy and its management in women with GSD type III - a single Centre experience","volume":"35","author":"Ramachandran","year":"2012","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1007\/s10545-007-0479-0","article-title":"A novel starch for the treatment of glycogen storage diseases","volume":"30","author":"Bhattacharya","year":"2007","journal-title":"J. Inherit. Metab. Dis."},{"issue":"0 1","key":"10.1016\/j.ymgmr.2021.100821_bb0135","article-title":"Reversal of glycogen storage disease type IIIa-related cardiomyopathy with modification of diet","volume":"32 Suppl 1","author":"Dagli","year":"2009","journal-title":"J. Inherit. Metab. Dis."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0140","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/ana.410110417","article-title":"Reversal of debrancher deficiency myopathy by the use of high-protein nutrition","volume":"11","author":"Slonim","year":"1982","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ymgmr.2021.100821_bb0145","first-page":"13","article-title":"Heart failure due to severe hypertrophic cardiomyopathy reversed by low calorie, high protein dietary adjustments in a glycogen storage disease type IIIa patient","volume":"5","author":"Sentner","year":"2012","journal-title":"JIMD Rep."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100821_bb0150","first-page":"17","article-title":"Modified Atkins ketogenic diet improves heart and skeletal muscle function in glycogen storage disease type III","volume":"38","author":"Francini-Pesenti","year":"2019","journal-title":"Acta Myol."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0155","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1159\/000509335","article-title":"Beneficial effects of modified Atkins diet in glycogen storage disease type IIIa","volume":"76","author":"Olgac","year":"2020","journal-title":"Ann. Nutr. Metab."},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100821_bb0160","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1203\/PDR.0b013e318232154f","article-title":"Successful treatment of severe cardiomyopathy in glycogen storage disease type III with D, L-3-hydroxybutyrate, ketogenic and high-protein diet","volume":"70","author":"Valayannopoulos","year":"2011","journal-title":"Pediatr. Res."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0165","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/jimd.12224","article-title":"Dietary lipids in glycogen storage disease type III: a systematic literature study, case studies, and future recommendations","volume":"43","author":"Rossi","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0170","doi-asserted-by":"crossref","first-page":"218","DOI":"10.7326\/0003-4819-120-3-199402010-00008","article-title":"Glycogen storage disease in adults","volume":"120","author":"Talente","year":"1994","journal-title":"Ann. Intern. Med."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100821_bb0175","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.transproceed.2006.10.018","article-title":"Nesiritide as bridge to multi-organ transplantation: a case report","volume":"39","author":"Cochrane","year":"2007","journal-title":"Transplant Proc."},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100821_bb0180","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1053\/j.gastro.2006.02.010","article-title":"Evidence-based incorporation of serum sodium concentration into MELD","volume":"130","author":"Biggins","year":"2006","journal-title":"Gastroenterology"},{"issue":"11","key":"10.1016\/j.ymgmr.2021.100821_bb0185","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.7863\/jum.2003.22.11.1155","article-title":"Roemerstein study group. Factors affecting liver size: a sonographic survey of 2080 subjects","volume":"22","author":"Kratzer","year":"2003","journal-title":"J. Ultrasound Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0190","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/jimd.12190","article-title":"Whole-body magnetic resonance imaging in late-onset pompe disease: clinical utility and correlation with functional measures","volume":"43","author":"Khan","year":"2020","journal-title":"J. Inherit. Metab. Dis."},{"issue":"12","key":"10.1016\/j.ymgmr.2021.100821_bb0195","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/00000478-199512000-00007","article-title":"Chronic hepatitis. An update on terminology and reporting","volume":"19","author":"Batts","year":"1995","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.ymgmr.2021.100821_bb0200","series-title":"GeneReviews\u00ae [Internet]","article-title":"Glycogen Storage Disease Type III. 2010 Mar 9 [updated 2016 Dec 29]","author":"Dagli","year":"1993"},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100821_bb0205","first-page":"41","article-title":"Natural progression of canine glycogen storage disease Type IIIa","volume":"66","author":"Brooks","year":"2016","journal-title":"Comp. Med."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100821_bb0210","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1399-3046.2007.00803.x","article-title":"Liver transplantation in children with glycogen storage disease: controversies and evaluation of the risk\/benefit of this procedure","volume":"12","author":"Davis","year":"2008","journal-title":"Pediatr. Transplant."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0215","first-page":"217","article-title":"Liver transplantation in a myopathic patient with glycogen storage disease type IIIa and decompensated\u00a0cirrhosis","volume":"8","author":"Zobeiri","year":"2017","journal-title":"Int. J. Organ. Transplant. Med."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0220","first-page":"537","article-title":"Type IIIb glycogen storage disease associated with end-stage cirrhosis and hepatocellular carcinomaThe Liver Transplant Group","volume":"25","author":"Haagsma","year":"1997"},{"key":"10.1016\/j.ymgmr.2021.100821_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.ymgme.2021.10.002","article-title":"Physical therapy assessment and whole-body magnetic resonance imaging findings in children with glycogen storage disease type IIIa: A clinical study and review of the literature","author":"Paschall","year":"2021","journal-title":"Mol. Genet. Metabol."},{"issue":"1","key":"10.1016\/j.ymgmr.2021.100821_bb0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1023\/B:BOLI.0000016632.13234.56","article-title":"Bone mineral density and markers of bone turnover in patients with glycogen storage disease types I, III and IX","volume":"27","author":"Cabrera-Abreu","year":"2004","journal-title":"J. Inherit. Metab. Dis."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0235","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.bone.2010.06.021","article-title":"Low bone mass in pompe disease: muscular strength as a predictor of bone mineral density","volume":"47","author":"Van den Berg","year":"2010","journal-title":"Bone"},{"issue":"10","key":"10.1016\/j.ymgmr.2021.100821_bb0240","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3389\/fendo.2019.00794","article-title":"Neuromuscular diseases and bone","volume":"22","author":"Iolascon","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100821_bb0245","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1210\/jc.2003-032046","article-title":"The prevalence and features of the polycystic ovary syndrome in an unselected population","volume":"89","author":"Azziz","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"7","key":"10.1016\/j.ymgmr.2021.100821_bb0250","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-7-11","article-title":"Endocrine manifestations related to inherited metabolic diseases in adults","volume":"28","author":"Vantyghem","year":"2012","journal-title":"Orphanet J. Rare Dis."},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100821_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3157","article-title":"Prevalence of diabetes in liver cirrhosis: a systematic review and meta-analysis","volume":"35","author":"Lee","year":"2019","journal-title":"Diabetes Metab. Res. Rev."},{"issue":"2","key":"10.1016\/j.ymgmr.2021.100821_bb0260","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1056\/NEJM198707093170203","article-title":"Myogenic hyperuricemia. A common pathophysiologic feature of glycogenosis types III, V, and VII","volume":"317","author":"Mineo","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"6","key":"10.1016\/j.ymgmr.2021.100821_bb0265","first-page":"804","article-title":"Characterization of a canine model of glycogen storage disease type IIIa","volume":"5","author":"Yi","year":"2012","journal-title":"Dis. Model. Mech."},{"issue":"1\u20132","key":"10.1016\/j.ymgmr.2021.100821_bb0270","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.mce.2009.08.013","article-title":"Stranger in a strange land: roles of glycogen turnover in adipose tissue metabolism","volume":"318","author":"Markan","year":"2010","journal-title":"Mol. Cell. Endocrinol."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0275","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10545-014-9789-1","article-title":"Cognitive profile of patients with glycogen storage disease type III: a clinical description of seven cases","volume":"38","author":"Michon","year":"2015","journal-title":"J. Inherit. Metab. Dis."},{"issue":"11","key":"10.1016\/j.ymgmr.2021.100821_bb0280","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1038\/s41436-020-0878-2","article-title":"The multiple faces of urinary glucose tetrasaccharide as biomarker for patients with hepatic glycogen storage diseases","volume":"22","author":"Heiner-Fokkema","year":"2020","journal-title":"Genet. Med."},{"issue":"8","key":"10.1016\/j.ymgmr.2021.100821_bb0285","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1023\/A:1005687323096","article-title":"Blood lipids and endothelial function in glycogen storage disease type III","volume":"22","author":"Hershkovitz","year":"1999","journal-title":"J. Inherit. Metab. Dis."},{"issue":"8","key":"10.1016\/j.ymgmr.2021.100821_bb0290","first-page":"E156","article-title":"Premature coronary artery disease in a patient with glycogen storage disease III","volume":"22","author":"LaBarbera","year":"2010","journal-title":"J Invasive Cardiol."},{"issue":"3","key":"10.1016\/j.ymgmr.2021.100821_bb0295","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/ajmg.10347","article-title":"Clinical and genetic variability of glycogen storage disease type IIIa: seven novel AGL gene mutations in the Mediterranean area","volume":"109","author":"Lucchiari","year":"2002","journal-title":"Am. J. Med. Genet."},{"issue":"4","key":"10.1016\/j.ymgmr.2021.100821_bb0300","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1002\/humu.9177","article-title":"Mutational analysis of the AGL gene: five novel mutations in GSD III patients","volume":"22","author":"Lucchiari","year":"2003","journal-title":"Hum. Mutat."},{"issue":"439","key":"10.1016\/j.ymgmr.2021.100821_bb0305","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cca.2014.10.016","article-title":"Molecular and clinical delineation of 12 patients with glycogen storage disease type III in Western Turkey","volume":"15","author":"Okubo","year":"2015","journal-title":"Clin. Chim. Acta"}],"container-title":["Molecular Genetics and Metabolism Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921001166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214426921001166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T12:52:14Z","timestamp":1762001534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214426921001166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":61,"alternative-id":["S2214426921001166"],"URL":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100821","relation":{},"ISSN":["2214-4269"],"issn-type":[{"value":"2214-4269","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A retrospective longitudinal study and comprehensive review of adult patients with glycogen storage disease type III","name":"articletitle","label":"Article Title"},{"value":"Molecular Genetics and Metabolism Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymgmr.2021.100821","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100821"}}